Logo image
Translational metabolomics in cancer research
Journal article   Open access   Peer reviewed

Translational metabolomics in cancer research

Nathaniel W. Snyder, Clementina Mesaros and Ian A. Blair
Biomarkers in medicine, v 9(9), pp 821-834
01 Jan 2015
PMID: 26329905
url
https://europepmc.org/articles/pmc4718447View
Accepted (AM)Open Access (License Unspecified) Open

Abstract

Life Sciences & Biomedicine Medicine, Research & Experimental Research & Experimental Medicine Science & Technology
Over the last decade there has been a bottleneck in the introduction of new validated cancer metabolic biomarkers into clinical practice. Unfortunately, there are no biomarkers with adequate sensitivity for the early detection of cancer, and there remain a reliance on cancer antigens for monitoring treatment. The need for new diagnostics has led to the exploration of untargeted metabolomics for discovery of early biomarkers of specific cancers and targeted metabolomics to elucidate mechanistic aspects of tumor progression. The successful translation of such strategies to the treatment of cancer would allow earlier intervention to improve survival. We have reviewed the methodology that is being used to achieve these goals together with recent advances in implementing translational metabolomics in cancer.

Metrics

5 Record Views
18 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
Web of Science research areas
Medicine, Research & Experimental
Logo image